Issue: January 2013
December 11, 2012
2 min read
Save

Norovirus may linger on dishes, utensils in restaurants

Issue: January 2013
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Norovirus appears harder than bacteria to remove from tableware through the standard sanitization processes used in many food service establishments, according to study results published online recently.

Perspective from Andi L. Shane, MD, MPH, MSc

Researchers from the department of food science and technology at The Ohio State University evaluated the sanitization efficacies of manual and mechanical protocols for washing all types of tableware and flatware used in restaurants. The investigators studied the survivability and response to the experimental conditions of Escherichia coli K-12 and Listeria innocua compared with murine norovirus 1 (MNV-1).

The findings indicate that the current protocols, which include sanitization with sodium hypochlorite (chlorine) and quaternary ammonium, did not achieve the required 5-log reduction in MNV-1. After washing, a maximum of 3-log reduction in the virus was obtained; tap water served as control.

Tableware and flatware in the study were contaminated with cream cheese and reduced-fat milk inoculated with MNV-1, E. coli K-12 and L. innocua.

“We know that when public food establishments follow the cleaning protocols, they do a very good job at getting rid of bacteria,” study researcher Melvin Pascall, PhD, said in a press release. “Now we can see that the protocols are less effective at removing and killing viruses — and this may help explain why there are still so many illnesses caused by cross-contaminated food.”

Norovirus is the leading cause of epidemic gastroenteritis worldwide and causes at least 50% of all US gastroenteritis outbreaks, according to the CDC.

The investigators plan to study hepatitis A and influenza viruses using the same study design.

Disclosure: The researchers report no relevant financial disclosures.